Targeting the Root Causes of Aging

INTRODUCTION

Aging is the primary risk factor for the majority of human chronic disease — and for most of medical history, it was treated as inevitable and largely untargetable. That is changing.

Over the past decade, aging biology has undergone a conceptual transformation. Rather than treating aging as a single, undifferentiated process of "wearing out," researchers have identified specific, interconnected cellular and molecular mechanisms — each of which can be measured, experimentally modulated, and in many cases meaningfully slowed or reversed by targeted interventions.

The framework that anchors this transformation is the hallmarks of aging — first proposed by López-Otín, Blasco, Partridge, Serrano, and Kroemer in a landmark 2013 paper in Cell [1], and significantly expanded in their 2023 update, "Hallmarks of Aging: An Expanding Universe," also published in Cell [2]. The original nine hallmarks have now been extended to twelve, incorporating disabled macroautophagy, chronic inflammation, and dysbiosis as formally recognized drivers of the aging process.

The hallmarks framework has been cited over 11,000 times since its introduction and serves as the foundational reference for virtually all current longevity research and therapeutic development. For practitioners, it provides something equally important: a map of the specific biological targets that determine how well — and how long — their patients' bodies function.

This white paper summarizes all twelve hallmarks, organized according to the three-tier classification introduced in the 2023 update, and maps each hallmark to the Healthgevity formulas designed to support it.

---

THE HALLMARKS FRAMEWORK — THREE TIERS

The 2023 López-Otín et al. update organized the 12 hallmarks into three functional categories:

Primary hallmarks — the initiating events. These cause damage that accumulates with age and exerts uniformly negative effects. They represent the upstream drivers from which downstream hallmarks flow.

Antagonistic hallmarks — context-dependent events. These are initially protective or adaptive responses to primary damage. With age and accumulating damage, however, they become chronically activated and transition from beneficial to detrimental.

Integrative hallmarks — the downstream consequences. These appear when the damage generated by the other two groups surpasses the capacity of homeostasis mechanisms, producing the tissue-level dysfunction that manifests as age-related disease and functional decline.

The interdependence of aging hallmarks means that the experimental accentuation or attenuation of one specific hallmark usually affects other hallmarks as well — underscoring the fact that aging is a complex process that has to be conceived as a whole.

---

PRIMARY HALLMARKS

The Initiating Events of Biological Aging

---

1. Genomic Instability

Every cell in the body faces a continuous assault on its DNA — from ultraviolet radiation, environmental toxins, reactive oxygen species generated during normal metabolism, errors in DNA replication, and spontaneous hydrolytic reactions. In youth, robust DNA repair systems — base excision repair, nucleotide excision repair, homologous recombination, and non-homologous end joining — keep pace with this damage. With age, both the rate of DNA damage and the efficiency of repair systems shift unfavorably [2].

The accumulation of unrepaired DNA lesions — strand breaks, base oxidations, crosslinks, and chromosome rearrangements — disrupts normal gene expression, drives cellular senescence, and contributes to the loss of tissue homeostasis that characterizes aging. Mitochondrial DNA is particularly vulnerable, lacking the protective histone packaging and comprehensive repair systems available to nuclear DNA [2].

Supporting DNA repair capacity is one of the most upstream interventions available in longevity medicine. Evidence suggests that certain natural compounds can support the enzymatic machinery of DNA repair — providing a meaningful clinical target even without pharmaceutical intervention.

Healthgevity formulas targeting this hallmark: Telomere Prime+ — ac-11® (42 published studies; supports DNA repair through base excision and nucleotide excision repair pathways; supports DNA repair following UV exposure in human studies) + Activated BroccoRaphanin™ (sulforaphane-mediated Nrf2 activation; upregulates NQO1, glutathione S-transferases, and HO-1) + Hobamine® (selective reactive dicarbonyl scavenger; neutralizes IsoLGs before they form permanent protein-DNA adducts)

NAC 900+ — glutathione synthesis support (GPx-mediated DNA protection from oxidative damage)

---

2. Telomere Attrition

Telomeres are the repetitive DNA sequences (TTAGGG)n that cap and protect the ends of chromosomes during cell division. With each replication cycle, telomeres shorten — because DNA polymerase cannot fully replicate the lagging strand terminus. When telomeres reach a critically short length, cells enter replicative senescence or apoptosis, withdrawing from the tissue renewal pool [2].

Telomere shortening is not solely a function of cell division. Oxidative DNA damage at telomeric sequences — which are particularly susceptible to 8-oxoguanine lesions due to their guanine-rich composition — accelerates attrition beyond replication-dependent rates. This makes oxidative stress management a meaningful upstream component of telomere longevity support [2].

The telomerase enzyme (TERT + TR) can extend telomeres in cells with sufficient expression — but most somatic cells have limited telomerase activity. Supporting the DNA maintenance environment that slows oxidative attrition, alongside ingredients with telomere-maintenance activity, represents the current evidence-based approach.

Healthgevity formulas targeting this hallmark: Telomere Prime+ — ac-11® (telomere length and integrity support during cellular mitosis; published evidence for telomere maintenance) + AstraGin® (Astragaloside IV; studied for telomerase activation support) + Puremidine® spermidine (epigenetic regulation of longevity-associated genes connected to telomere maintenance)

---

3. Epigenetic Alterations

The epigenome — the system of chemical modifications to DNA and histone proteins that regulate gene expression without altering the underlying sequence — undergoes systematic and measurable changes with age. Global hypomethylation of repetitive genomic elements combined with hypermethylation at specific promoter regions, altered histone modification patterns, and changes in chromatin accessibility collectively disrupt the normal gene expression programs that maintain cellular identity and function [2].

Epigenetic age — measured by DNA methylation clocks such as Horvath's or GrimAge — has emerged as one of the most robust biological aging biomarkers available. It tracks chronological age closely, predicts mortality and morbidity more accurately than chronological age in many studies, and can be shifted by specific dietary and nutritional interventions [2].

Alpha-ketoglutarate (AKG) is particularly relevant here — as a co-substrate for TET enzymes and Jumonji-domain demethylases that regulate DNA methylation and histone modification, AKG availability directly influences the epigenetic maintenance machinery.

Healthgevity formulas targeting this hallmark: Prime Time+ (Stem Cell) — AKG (TET/JmjC co-substrate; epigenetic longevity regulation) + Puremidine® spermidine (histone deacetylase inhibition and epigenetic longevity gene regulation)

NMN 1000+ — NAD+ precursor (NAD+-dependent SIRT1/SIRT6 histone deacetylase activity; epigenetic maintenance)

Cardio NAD+ — NAD3® + Niacinamide (NAD+/NADH ratio optimization; sirtuin-dependent histone deacetylation)

---

4. Loss of Proteostasis

Proteostasis — the maintenance of a functional, properly folded cellular proteome — depends on the coordinated activity of protein synthesis machinery, molecular chaperones (heat shock proteins, HSP70, HSP90), the ubiquitin-proteasome system, and autophagy. With age, all of these systems decline, and the cell's capacity to clear damaged, misfolded, or aggregated proteins deteriorates [2].

The consequences are evident in the hallmark diseases of aging: Alzheimer's disease (amyloid-β and tau aggregates), Parkinson's disease (α-synuclein aggregates), type 2 diabetes (IAPP/islet amyloid), and cardiovascular aging (transthyretin amyloid) all involve the accumulation of misfolded protein species that functional proteostasis would ordinarily clear.

Proteostasis maintenance is directly connected to the autophagy hallmark — macroautophagy is one of the primary routes for clearing protein aggregates too large for the proteasome.

Healthgevity formulas targeting this hallmark: Prime Time+ (Stem Cell) — Puremidine® spermidine (autophagy induction; protein quality control; epigenetic regulation of proteostasis-related gene expression)

Rejuvenate (Senolytic) — Puremidine® spermidine (weekly high-dose autophagy pulse) + MitoPrime® L-Ergothioneine (mitochondrial protein protection)

Mitochondria Prime+™ — Algevity® (Nrf2 activation; upregulates protein quality control genes) + Naturalin™ Pro (Urolithin A; mitophagy — selective clearance of damaged mitochondrial proteins)

---

ANTAGONISTIC HALLMARKS

Adaptive Responses That Become Harmful With Age

---

5. Deregulated Nutrient Sensing

Four interconnected nutrient-sensing networks — insulin/IGF-1 signaling, mTORC1, AMPK, and sirtuins — collectively govern how cells respond to nutrient availability and energy status. In youth, these systems operate in a balanced, context-appropriate way. With age, the balance shifts: mTORC1 becomes constitutively hyperactivated (promoting anabolic activity and suppressing autophagy even in the absence of nutrient surplus), while AMPK and sirtuin activity decline (reducing catabolic efficiency and stress resistance) [2].

The result is a cellular metabolic state increasingly associated with insulin resistance, impaired autophagy, mitochondrial inefficiency, and accelerated aging. Caloric restriction and intermittent fasting extend lifespan in model organisms primarily through modulating these same pathways — making nutrient sensing one of the most therapeutically actionable hallmarks through nutritional intervention.

Healthgevity formulas targeting this hallmark: GlucoPrime™ — Reducose® (−30-33% post-meal glucose; alpha-glucosidase inhibition) + BioMetaControl™ (HNF4α "master metabolic switch" activation; n=126 RCT) + GlucoVantage® (AMPK activation; dihydroberberine) + InnoSlim® (intestinal glucose reduction; GLUT4 upregulation) + Naturalin® (GLUT4 signaling)

NMN 1000+ — pterostilbene (SIRT1/SIRT3 activation) + apigenin (CD38 inhibition; NAD+ conservation for sirtuin activity)

Ignite+ — GlucoVantage® (AMPK) + Factor21® (FGF21/adiponectin) + MitoBurn® L-BAIBA (exercise-mimetic AMPK/PGC-1α activation)

Cardio NAD+ — NAD3® (NAD+/NADH optimization; sirtuin substrate support)

---

6. Mitochondrial Dysfunction

Mitochondria are the primary sites of cellular energy production — and the primary source of endogenous reactive oxygen species (ROS). In a functional feedback loop, mitochondrial ROS at low levels activate adaptive stress responses (mitohormesis) that strengthen the cell. With age, however, mitochondrial quality declines: electron transport chain complex activity decreases, membrane potential drops, mtDNA mutation burden accumulates, and the mitophagy machinery that clears dysfunctional mitochondria becomes less efficient [2].

The result is a progressive shift toward lower ATP output, higher ROS generation, impaired calcium handling, and increased apoptotic signaling — with consequences in every high-energy-demand tissue including skeletal muscle, heart, brain, and kidney.

Mitochondrial decline is one of the most cross-cutting hallmarks — it contributes to virtually every other hallmark through its effects on energy availability, oxidative stress, inflammation, and cellular quality control.

Healthgevity formulas targeting this hallmark: Mitochondria Prime+™ — ALCAR (fatty acid transport; mitochondrial bioenergetics) + Riboflavin-5'-Phosphate (ETC cofactor FAD/FMN) + Algevity® (Nrf2; >200 cytoprotective genes) + MitoPrime® (mitochondrial-selective antioxidant accumulation) + Astaxanthin (membrane-spanning lipid peroxidation protection) + Naturalin™ Pro (Urolithin A/B; mitophagy renewal)

Cardio NAD+ — NAD3® (NAD+/NADH; ETC efficiency) + CoQ10 with LEO-HB® (mitochondrial electron transport; membrane antioxidant)

NEUROgevity™ — SalidroPure® salidroside (PGC-1α; mitochondrial biogenesis; AMPK/SIRT1 activation) + MitoPrime® (neuronal mitochondrial protection)

---

7. Cellular Senescence

Cellular senescence is the state of permanent cell cycle arrest entered by cells in response to DNA damage, oncogene activation, oxidative stress, or telomere shortening. In youth, senescence is a beneficial tumor-suppressive response and contributes to wound healing. With age, senescence increases beyond physiological levels, hampering the proper function of the organism.

The accumulating burden of senescent cells drives aging through the senescence-associated secretory phenotype (SASP) — a cocktail of pro-inflammatory cytokines, matrix metalloproteinases, chemokines, and growth factors that creates a chronically inflammatory tissue microenvironment, impairs regeneration, induces bystander senescence in neighboring cells, and drives systemic "inflammaging" [2].

Senolytics — compounds that selectively eliminate senescent cells — have emerged as one of the most promising classes of longevity interventions. Multiple human clinical trials are now underway at Mayo Clinic, Harvard, and other centers. Senomorphics — compounds that suppress SASP without eliminating senescent cells — represent a complementary approach.

Healthgevity formulas targeting this hallmark: Rejuvenate (Senolytic) — Fisetin (primary senolytic; Bcl-2 pathway; Mayo Clinic trials active) + Quercetin Phytosome® (20x bioavailability; senolytic + senomorphic) + Senactiv® (muscle-specific senolytic; 9/12 human subjects showed complete senescent cell elimination post-HIIT) + TurmiPure GOLD® 24x + CurcuPrime® (SASP inflammatory modulation)

Longevity — Senactiv® (muscle senolytic renewal; 47% citrate synthase increase; 2.7x glycogen accumulation)

Prime Time+ (Stem Cell) — Puremidine® spermidine (2025 RCT: reduced p16 immune cell senescence; enhanced autophagy)

---

8. Disabled Macroautophagy (New in 2023)

Macroautophagy — the cellular process of sequestering damaged organelles, protein aggregates, and intracellular pathogens into autophagosomes for lysosomal degradation and recycling — is one of the cell's primary quality-control mechanisms. Its progressive decline with age is now recognized as a hallmark in its own right, reflecting both its central importance and the growing evidence that restoring autophagy can meaningfully extend healthspan [2].

Autophagy declines are multifactorial: mTORC1 hyperactivation suppresses autophagy initiation, lysosomal function deteriorates with age, and the expression of key autophagy genes (Beclin-1, ATG5, ATG7) decreases in multiple tissues. The consequence is accumulation of cellular debris — dysfunctional mitochondria, oxidized proteins, lipid droplets — that impairs cellular function and drives the senescent and inflammatory phenotypes described in adjacent hallmarks.

Spermidine has been identified as the most strongly supported mechanism behind autophagy activation in longevity research, with the 2024 Nature Cell Biology paper specifically demonstrating that spermidine is essential for fasting-mediated autophagy and longevity — explaining a significant portion of caloric restriction's benefits at the molecular level.

Healthgevity formulas targeting this hallmark: Prime Time+ (Stem Cell) — Puremidine® spermidine 10 mg (master autophagy activator; 2024 Nature Cell Biology; 2025 immune senescence RCT) + Fucoidan (complementary autophagy pathway support) + Luteolin + Apigenin (mTOR pathway modulation)

Rejuvenate (Senolytic) — Puremidine® spermidine 10 mg (weekly high-dose autophagy pulse alongside senolytic activity)

Mitochondria Prime+™ — Naturalin™ Pro Urolithin A/B (mitophagy — selective autophagy of damaged mitochondria; human RCT evidence)

---

INTEGRATIVE HALLMARKS

Downstream Consequences When Homeostasis Fails

---

9. Stem Cell Exhaustion

Adult stem cells — residing in specialized niches across bone marrow, gut epithelium, skeletal muscle, brain, and skin — maintain tissue homeostasis by providing a continuous supply of differentiated cells to replace those lost to wear, damage, or programmed death. With age, both the number and functional capacity of stem cells decline, driven by the cumulative damage from the primary hallmarks: telomere shortening, DNA damage, epigenetic drift, and oxidative stress [2].

The clinical consequences are tissue-specific but pervasive: declining hematopoiesis and immune senescence from bone marrow stem cell exhaustion, impaired muscle regeneration from satellite cell decline, reduced neurogenesis from neural stem cell depletion, and compromised epithelial renewal from intestinal stem cell dysfunction.

Circulating bone marrow-derived CD34+ hematopoietic stem cells are one measurable parameter for regenerative reserve — and their mobilization into peripheral circulation is a physiological mechanism by which the body directs stem cells to sites of tissue maintenance.

Healthgevity formulas targeting this hallmark: Prime Time+ (Stem Cell) — StemEnhance® (human double-blind study: significant increase in circulating CD34+ stem cells within 48 hours; crossover study n=21: broad lymphocyte and monocyte mobilization) + AstraGin® (Astragaloside IV; stem cell renewal signaling support)

---

10. Altered Intercellular Communication

Cells communicate through paracrine and endocrine signaling — secreted proteins, extracellular vesicles, metabolites, and direct contact. Aging disrupts this communication network in several directions: inflammatory cytokine signaling increases (inflammaging, driven partly by SASP), trophic factor signaling decreases (declining BDNF, IGF-1, and growth hormone), and the systemic circulation increasingly carries pro-aging factors from senescent and dysfunctional tissues [2].

The vascular glycocalyx — the carbohydrate-rich layer coating endothelial cells — plays a critical role in intercellular communication at the vascular interface, regulating molecular exchange between blood and tissues. Its degradation with age impairs this function.

Healthgevity formulas targeting this hallmark: Cardio NAD+ — Fucoidan/Mekabu (glycocalyx integrity; 2024 JACC: vascular calcification support) + PeptiPump® (ACE/RAS vascular signaling) + FitNox® (nitric oxide endothelial signaling)

Longevity — PeptiPump® (ACE-modulating vascular signaling; muscle nutrient delivery)

bioREPAIR™ — MaolactinGI™ + MaolactinFMR™ (gut-muscle axis signaling; biofunctional proteins with ≥95% human biosimilarity)

---

11. Chronic Inflammation (New in 2023)

"Inflammaging" — the chronic, low-grade, sterile inflammation that increases with age — is now formally recognized as an integrative hallmark rather than simply a consequence of other hallmarks. It is driven by multiple converging sources: SASP from senescent cells, gut dysbiosis-derived LPS translocation, mitochondrial DNA leakage into the cytoplasm (activating innate immune sensing), and declining regulatory T-cell activity [2].

Chronic inflammation simultaneously drives and is driven by other hallmarks — particularly cellular senescence, dysbiosis, and mitochondrial dysfunction — creating self-amplifying feedback loops that accelerate biological aging across tissue types. It is the common inflammatory thread linking the hallmarks to age-related disease: cardiovascular disease, type 2 diabetes, neurodegeneration, cancer, and sarcopenia all have inflammaging as a significant contributing mechanism.

Healthgevity formulas targeting this hallmark: Resolve+ (Inflammatory Balance) — Acmella oleracea/spilanthol (CB2 agonism; FAAH inhibition; NF-κB suppression) + Theracurmin Super® 85X (NF-κB pathway; cytokine balance) + Casperome® Boswellia (5-LOX inhibition) + Quercetin Phytosome® 20X (broad inflammatory modulation)

Rejuvenate (Senolytic) — addresses the senescent cell source of SASP-driven inflammaging

NAC 900+ — glutathione synthesis (GPx/SOD antioxidant enzyme activity; oxidative stress → inflammation axis)

immunoRESTORE+ — IMMUSE® LC-Plasma (pDC activation; balanced innate immune calibration) + effera® lactoferrin (mucosal immune balance)

---

12. Dysbiosis (New in 2023)

The gut microbiome undergoes significant compositional and functional changes with age — decreased diversity, reduced abundance of beneficial Bifidobacterium and Akkermansia muciniphila populations, increased abundance of pro-inflammatory pathobionts, and declining short-chain fatty acid (SCFA) production. This dysbiotic shift contributes to gut barrier dysfunction, increased intestinal permeability, systemic LPS translocation, and the chronic inflammatory tone that characterizes aging [2].

Gut dysbiosis and the hallmarks of aging interact bidirectionally: dysbiosis drives inflammaging and impairs immune function, while SASP inflammation from other hallmarks alters the gut environment. The gut microbiome is increasingly recognized not as a passive bystander in aging but as an active modulator of biological aging rate — with the composition of an 80-year-old's microbiome predicting functional status, resilience, and longevity outcomes independently of other factors.

Healthgevity formulas targeting this hallmark: Prime Gut Health — ImmunoLin® SBI (IgG binding of LPS; gut barrier integrity; 40+ human studies; IPA production) + CoreBiome® Tributyrin (colonic butyrate delivery; Akkermansia + Bifidobacterium support) + SNZ TriBac Sporebiotics (microbiome reconditioning; IBS-D clinical evidence)

immunoRESTORE+ — 2'-FL HMO (selective Bifidobacterium prebiotic; 6-week RCT: targeted microbiome shift + systemic immune alteration) + effera® (gut barrier integrity; microbiome environment support)

Colostrum-GI Bio-Biotic™ — MaolactinGI™ Pro 620 mg (bio-biotic; gut barrier repair; 7x efficacy vs standard colostrum; double-blind RCT)

bioREPAIR™ — MaolactinGI™ + MaolactinFMR™ (gut barrier + muscle recovery axis; LPPDS™ delivery)

---

THE HALLMARKS — SUMMARY TABLE

---

CONCLUSION

The twelve hallmarks of aging do not operate in isolation. Each drives and is driven by the others — creating the self-amplifying biological aging process that accumulates over decades. This interconnectedness has an important clinical implication: comprehensive longevity support requires addressing multiple hallmarks simultaneously, through a systems-based approach that targets the full network rather than any single pathway.

This is the principle that governs every Healthgevity formula. Each product is designed to address specific hallmarks through clinically validated, mechanistically distinct ingredients — with the catalog as a whole providing the coverage across all twelve hallmarks that no single formula could achieve.

For practitioners building longevity protocols, the hallmarks framework provides the clinical map. Healthgevity provides the formulas designed to address it.

[Explore the full Healthgevity catalog →] [Apply for a Practitioner Account →] [Visit the Healthgevity Institute →]

---

REFERENCES

[1] López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013 Jun 6;153(6):1194-217. doi: 10.1016/j.cell.2013.05.039. PMID: 23746838.

[2] López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: An expanding universe. Cell. 2023 Jan 19;186(2):243-278. doi: 10.1016/j.cell.2022.11.001. Epub 2023 Jan 3. PMID: 36599349.

[3] Schmauck-Medina T, Molière A, Lautrup S, et al. New hallmarks of ageing: a 2022 Copenhagen ageing meeting summary. Aging (Albany NY). 2022 Aug 8;14(16):6829-6839. doi: 10.18632/aging.204248. PMID: 35940694; PMCID: PMC9467401.

[4] López-Otín C, Kroemer G. Hallmarks of Health. Cell. 2021 Jan 7;184(1):33-63. doi: 10.1016/j.cell.2020.11.034. PMID: 33340459.

[5] Xu M, Pirtskhalava T, Farr JN, et al. Senolytics improve physical function and increase lifespan in old age. Nat Med. 2018 Aug;24(8):1246-1256. doi: 10.1038/s41591-018-0092-9. PMID: 29988130.

[6] Eisenberg T, Knauer H, Schauer A, et al. Induction of autophagy by spermidine promotes longevity. Nat Cell Biol. 2009 Nov;11(11):1305-14. doi: 10.1038/ncb1975. PMID: 19801973.

[7] Madeo F, Carmona-Gutierrez D, Hofer SJ, Kroemer G. Caloric Restriction Mimetics against Age-Associated Disease: Targets, Mechanisms, and Therapeutic Potential. Cell Metab. 2019 Mar 5;29(3):592-610. doi: 10.1016/j.cmet.2019.01.018. PMID: 30840912.

---

This white paper is for educational purposes for healthcare professionals. These statements have not been evaluated by the Food and Drug Administration. Healthgevity products are not intended to diagnose, treat, cure, or prevent any disease.

Last updated: 2026. Healthgevity, LLC. All rights reserved.